Mitochondria-augmented Cell Therapy represents a paradigm shift in regenerative medicine, designed to overcome the metabolic limitations of traditional autologous cell treatments. By isolating a patient’s own stem or immune cells and enriching them with healthy, functional mitochondria, the technology actively restores cellular bioenergetic capacity. This process transforms standard biological material into metabolically optimized therapeutic agents, ensuring that the cells reintroduced to the body possess superior viability, potency, and the energy required to maximize clinical efficacy
We combine autologous stem cells with functional mitochondria to enhance cellular health and therapeutic potential. This process ensures a personalized and biocompatible approach for mitochondrial-based regenerative treatments.
Cells are collected from the patient
The patient’s own stem cells are harvested, either from blood (which is called hematopoietic stem cells/HSCs), SVF (adipose mesenchymal stem cells/ ADMSCs) or bone marrow (bone marrow stem cells/BMSc)
Mitochondria is incorporated into the cells
Our GMP-grade functional healthy mitochondria is added into the cells to form mitochondria-augmented stem cells.
The mitochondria-augmented stem cells are injected into the patient
At PAEAN Biotechnology, our GMP (Good Manufacturing Practice) facility upholds the highest international standards for quality and safety. We are committed to meticulous control at every stage, from raw material sourcing to final product formulation.
Equipped with advanced technology and expert personnel, our facility ensures the purity, potency, and safety of our mitochondrial cell therapies. This rigorous approach underpins our mission to deliver innovative and reliable treatments to patients.
Headquarter : #108SB, DaeduckBiz Center
17 Techno 4-ro, Yuseong-gu, Daejeon 34013, Korea
Mail : info@paeanbio.com
Phone : 042-334-7378 | Fax : 042-334-7096
Copyrights © 2025 All Rights Reserved by PAEAN BIOTECHNOLOGY